Primary Pulmonary Hypertension (PPH) caused by Avandia?
Primary Pulmonary Hypertension (PPH) also referred to as Primary Arterial Hypertension (PAH) are serious and aggressive heart and lung diseases that narrow the blood vessels in the lungs. This narrowing of the blood vessels leads to higher arterial blood pressure within the lung and heart. This increased pulmonary hypertension leads to serious heart and lung damage, heart failure, heart attacks and possible strokes. PPH has been linked to the use of the popular diet drugs known as Fen-Phen, Pondimin, Redux and to herbal nutritional supplements containing ephedra PPH (ma huang),St. John's Wort PPH and recently a possible link to the use of diabetes drug called Avandia PPH. Avandia distributed by GlaxoSmithKline. Avandia is used to treat patients with type 2 diabetes.
In 2007, the Food & Drug Administration (FDA) and GlaxoSmithKline issued a warning letter (Dear Dr. Letter) treating doctors of Avandia patients of a potential link between Avandia and the onset of Primary Pulmonary Hypertension. See Avandia side effects for more news about increased risks.
Willis Law Firm - Houston, Texas Drug Injury Lawyer and Attorney Free Lawsuit & Class Action Lawsuit Lawyer
LEGAL ADVERTISING
THIS WEBSITE IS NOT A MEDICAL SITE
This is an Attorney / Lawyer Advertising Website. It is not a medical information, medical dictionary, medical advice or medical help site. Talk to you own treating Doctor about any questions or concerns that you have concerning any medicine, drug, medical device or treatment plan. Do not rely on any information on this site to alter, stop or change any medication or treatment plan by your prescribing or treating Doctor. Many of the drugs and devices listed here on this site have published risk and warnings associated with their use and have not been recalled. This website is not in anyway connected with any drug company or the FDA.Check with your Doctor, Pharmacy and/or the FDA as to any concerns as to their use, recall status and safety. See http://www.fda.gov/ for the latest information.
Principal Office -Willis Law Firm 5005 Riverway Drive, Suite #160 Houston, Texas 77056
